[
  {
    "ts": "2026-01-05T15:08:24+00:00",
    "headline": "A Look At Viatris (VTRS) Valuation After Recent Regulatory And Pipeline Milestones",
    "summary": "Viatris (VTRS) shares are back in focus after the company reported four regulatory milestones, including US FDA approval for a generic octreotide acetate injectable and progress on contraceptive, gene therapy, and sleep-disorder treatments. See our latest analysis for Viatris. These pipeline updates arrive as Viatris shares trade at $12.46, with a 30 day share price return of 14.0% and a 90 day share price return of 22.88%, while the 1 year total shareholder return is 9.57% and the 3 year...",
    "url": "https://finance.yahoo.com/news/look-viatris-vtrs-valuation-recent-150824170.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3b36f437-254a-3c05-9347-d92f55f6e491",
      "content": {
        "id": "3b36f437-254a-3c05-9347-d92f55f6e491",
        "contentType": "STORY",
        "title": "A Look At Viatris (VTRS) Valuation After Recent Regulatory And Pipeline Milestones",
        "description": "",
        "summary": "Viatris (VTRS) shares are back in focus after the company reported four regulatory milestones, including US FDA approval for a generic octreotide acetate injectable and progress on contraceptive, gene therapy, and sleep-disorder treatments. See our latest analysis for Viatris. These pipeline updates arrive as Viatris shares trade at $12.46, with a 30 day share price return of 14.0% and a 90 day share price return of 22.88%, while the 1 year total shareholder return is 9.57% and the 3 year...",
        "pubDate": "2026-01-05T15:08:24Z",
        "displayTime": "2026-01-05T15:08:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pVOKMAerbRsXv56pHka6Lw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EmyGBi4taxQExvvwka_9KQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-viatris-vtrs-valuation-recent-150824170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-viatris-vtrs-valuation-recent-150824170.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]